Research Article
Continuation of Aspirin Therapy before Cataract Surgery with Different Incisions: Safe or Not?
Table 1
Demographic characteristics.
| Parameter | Continuation group | Discontinuation group | Control group | value |
| Patients, | 81 | 85 | 94 | — |
| Eye, | 112 | 124 | 121 | — | Sex, | | | | 0.223a | Male | 46 | 39 | 42 | | Female | 35 | 46 | 52 | |
| Age, year | | | | 0.193b | Mean ± SD | 75.2 ± 8.6 | 76.3 ± 7.3 | 74.5 ± 8.0 | | Range | 50–93 | 55–90 | 58–89 | |
| BCVA, logMAR | | | | 0.165b | Mean ± SD | 0.58 ± 0.19 | 0.61 ± 0.18 | 0.62 ± 0.17 | |
| IOP, mmHg | | | | 0.210b | Mean ± SD | 15.9 ± 2.6 | 15.2 ± 2.6 | 15.6 ± 2.9 | |
| Aspirin duration, month | | | | 0.119c | Median (IQR) | 60 (24–96) | 60 (36–120) | — | |
| Type of incision, | | | | 0.706a | Corneal incision | 57 | 60 | 65 | | Scleral incision | 55 | 64 | 56 | |
|
|
BCVA = best-corrected visual acuity; IOP = intraocular pressure; achi-square test; bStudent’s t-test; CWilcoxon rank sum test.
|